IDEAYA Biosciences to Participate in Investor Conferences in September 2021

SOUTH SAN FRANCISCO, Calif.: SOUTH SAN FRANCISCO, Calif., Aug. 30, 2021 /PRNewswire/ -- IDEAYA Biosciences, Inc. (NASDAQ: IDYA), a synthetic lethality-focused precision medicine oncology company committed to the discovery and development of targeted therapeutics, announced its participation in investor conferences in September 2021. Citi's 16th Annual BioPharma Virtual ConferenceYujiro Hata,...

Click to view original post